Sierra Oncology Net Income

Sierra Oncology (SRRA) currently reports a net income of $-100M as of March 2022. That compares with $-69M in the prior-year period — down 49.0% year over year. That is below the Healthcare sector average of $16B. Use the charts on this page to explore Sierra Oncology's net income history and peer comparisons.

Sierra Oncology's net income decreased from $-69M to $-100M — a 49.0% year-over-year decrease (period ending March 2022). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Sierra Oncology's net income of $-100M is lower than the Healthcare sector average of $16B. That is roughly 100.6% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

Sierra Oncology reported $-100M in net income as of March 2022. That compares with $-69M in the prior-year period — down 49.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current net income of $-100M, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is $16B. From there, open related valuation or income-statement pages for Sierra Oncology, and consider following SRRA for alerts when major investors trade the stock.